Russian experts have claimed in the results of Phase II of the clinical trial of the locally developed corona vaccine Sputnik V that the vaccine is up to 95% effective against the corona epidemic. The government-run Gamalia Research Center and the Russian Foreign Investment Fund (RDIF) said the findings were based on preliminary data obtained